Phosphinegold(I) Thiolates – Pharmacological Use and Potential
Open Access
- 1 January 2003
- journal article
- Published by Wiley in Bioinorganic Chemistry and Applications
- Vol. 1 (1) , 53-67
Abstract
A brief overview of the use of gold compounds in medicine, namely in the treatment of rheumatoid arthritis is presented, including that of the orally-administered triethylphosphinegold(I) tetraacetylatedthioglucose species, auranofin. A summary of an evaluation for anti-arthritic activity of novel phosphinegold(I) thiolate analogues containing biologically active thiols is given. This shows that compounds with greater efficacy and reduced toxic side-effects, at least in the in vivo model studied, can be developed. More recent investigations on this class of compound have focussed on their putative anti-tumour activity. Significant cytotoxicity and apparent cellular specificity have been discovered for certain phosphinegold(I) thiolates carrying water-solubilising groups. All indications are there that the continued exploration of the medicinal properties of phosphinegold(I) thiolates offers very real opportunities in metallotherapeutics.Keywords
Funding Information
- National University of Singapore (R-143-000-139-112, R-143-000-175-305)
- Biomedical Research Council Singapore (R-143-000-139-112, R-143-000-175-305)